We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

125 hedge funds and large institutions have $1.33B invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 10

112% more call options, than puts

Call options by funds: $989K | Put options by funds: $466K

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

27% more capital invested

Capital invested by funds: $1.05B → $1.33B (+$278M)

25% more funds holding

Funds holding: 100 → 125 (+25)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
125
Holders Change
+25
Holders Change %
+25%
% of All Funds
1.79%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
35
Increased
54
Reduced
28
Closed
10
Calls
$989K
Puts
$466K
Net Calls
+$523K
Net Calls Change
+$1.17M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$32.4M
2
Goldman Sachs
Goldman Sachs
New York
+$24.2M
3
BlackRock
BlackRock
New York
+$16.2M
4
EA
Emerald Advisers
Pennsylvania
+$15.7M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$13.8M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$88.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$27.9M
3
JP Morgan Chase
JP Morgan Chase
New York
-$17.5M
4
PCH
Polar Capital Holdings
United Kingdom
-$8.67M
5
PHP
Parkman Healthcare Partners
Connecticut
-$6.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Candriam SCA
Luxembourg
$12M +$4.64M +134,872 +60%
CIBC Asset Management
27
CIBC Asset Management
Ontario, Canada
$11.4M +$1.03K +30 +0%
SCM
28
Soleus Capital Management
Connecticut
$10.6M +$11M +318,269 New
N
29
Nuveen
North Carolina
$10.3M +$5.13M +149,129 +93%
BSA
30
Braun Stacey Associates
New York
$9.97M +$10.3M +299,156 New
Northern Trust
31
Northern Trust
Illinois
$9.53M +$2.52M +73,100 +34%
Charles Schwab
32
Charles Schwab
California
$8.69M +$5.96M +173,053 +197%
ABG
33
Ally Bridge Group
New York
$8.03M +$754K +21,911 +10%
TD Asset Management
34
TD Asset Management
Ontario, Canada
$6.01M +$468K +13,600 +8%
O
35
OrbiMed
New York
$5.67M +$5.85M +170,000 New
NFGH
36
Nan Fung Group Holdings
Hong Kong
$5.35M +$551K +16,000 +11%
SCM
37
Silverarc Capital Management
Massachusetts
$4.14M +$51.8K +1,504 +1%
PHS
38
PFM Health Sciences
California
$3.79M +$3.92M +113,711 New
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.78M -$149K -4,328 -4%
EI
40
EAM Investors
California
$3.7M +$2.94M +85,456 +335%
RAM
41
Readystate Asset Management
Illinois
$3.58M +$3.7M +107,345 New
PIM
42
Platinum Investment Management
Australia
$3.46M -$351K -10,189 -9%
JP Morgan Chase
43
JP Morgan Chase
New York
$3.27M -$17.5M -508,600 -84%
Prudential Financial
44
Prudential Financial
New Jersey
$2.71M – – –
Bank of New York Mellon
45
Bank of New York Mellon
New York
$2.48M -$630K -18,287 -20%
VOYA Investment Management
46
VOYA Investment Management
Georgia
$2.38M +$1.21M +35,201 +97%
Deutsche Bank
47
Deutsche Bank
Germany
$2.27M +$1.88M +54,485 +396%
Swiss National Bank
48
Swiss National Bank
Switzerland
$2.15M +$286K +8,300 +15%
Barclays
49
Barclays
United Kingdom
$2.06M +$1.33M +38,669 +167%
DC
50
Decheng Capital
California
$1.88M +$1.94M +56,350 New
1
2
3 4 5

LBPH Hedge Fund Activity: Q3 2024 in Review

125 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q3 2024, worth a combined $1.33B — up 27% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new LBPH positions and 10 closed out — a net gain of 25 holders — while 54 added to existing stakes and 28 trimmed.

The largest buyer was Woodline Partners, adding an estimated $32.4M. The largest seller was RA Capital Management, exiting entirely with an estimated $88.9M sold.

  • 125 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q3 2024, up from 100 in Q2 2024.
  • Funds reported $1.33B of Longboard Pharmaceuticals, Inc. Common Stock stock for Q3 2024, up 27% quarter-over-quarter.
  • 35 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q3 2024 and 10 closed out, a net change of +25 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q3 2024 was Woodline Partners, an estimated $32.4M added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q3 2024 was RA Capital Management, an estimated $88.9M sold.

Based on aggregated 13F filings for Q3 2024.